Page last updated: 2024-09-02

carboxyamido-triazole and Still's Disease, Adult-Onset

carboxyamido-triazole has been researched along with Still's Disease, Adult-Onset in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Duan, M; Guo, Z; He, Y; Li, J; Shen, M; Ye, C; Zhou, Y; Zhu, L	1

Other Studies

1 other study(ies) available for carboxyamido-triazole and Still's Disease, Adult-Onset

Article	Year
AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole. Clinical rheumatology, 2023, Volume: 42, Issue:6 Topics: Adult; Calcium-Binding Proteins; CARD Signaling Adaptor Proteins; Cytokines; DNA-Binding Proteins; Humans; Inflammasomes; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Messenger; Still's Disease, Adult-Onset; Tumor Necrosis Factor-alpha	2023

Article

Year

AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.

Clinical rheumatology, 2023, Volume: 42, Issue:6

Topics: Adult; Calcium-Binding Proteins; CARD Signaling Adaptor Proteins; Cytokines; DNA-Binding Proteins; Humans; Inflammasomes; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; NLR Family, Pyrin Domain-Containing 3 Protein; RNA, Messenger; Still's Disease, Adult-Onset; Tumor Necrosis Factor-alpha

2023